Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
    • CME
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CCR Focus Archive
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Breast Cancer
      • Clinical Trials
      • Immunotherapy: Facts and Hopes
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Clinical Cancer Research
Clinical Cancer Research
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
    • CME
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CCR Focus Archive
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Breast Cancer
      • Clinical Trials
      • Immunotherapy: Facts and Hopes
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Biology of Human Tumors

Validation of Biomarkers That Complement CA19.9 in Detecting Early Pancreatic Cancer

Alison Chan, Ioannis Prassas, Apostolos Dimitromanolakis, Randall E. Brand, Stefano Serra, Eleftherios P. Diamandis and Ivan M. Blasutig
Alison Chan
1Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.
2Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ioannis Prassas
1Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.
2Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Apostolos Dimitromanolakis
2Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Randall E. Brand
3University of Pittsburgh, Division of Gastroenterology, Hepatology & Nutrition, Pittsburgh, Pennsylvania.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stefano Serra
1Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.
4Department of Pathology, University Health Network, Toronto, Ontario, Canada.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eleftherios P. Diamandis
1Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.
2Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada.
5Department of Clinical Biochemistry, University Health Network, Toronto, Ontario, Canada.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ivan M. Blasutig
1Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.
5Department of Clinical Biochemistry, University Health Network, Toronto, Ontario, Canada.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: ivan.blasutig@uhn.ca
DOI: 10.1158/1078-0432.CCR-14-0289 Published November 2014
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Online Impact

Statistics from Altmetric.com

ARTICLE USAGE

ARTICLE USAGE: September 2014 to January 2021

AbstractFull-text HTMLPDF
Total343219191837

Cited By

Article Information

Volume 20, Issue 22, pp. 5787-5795

DOI 
https://doi.org/10.1158/1078-0432.CCR-14-0289
PubMed 
25239611

Published By 
American Association for Cancer Research
Print ISSN 
1078-0432
Online ISSN 
1557-3265
History 
  • Received February 11, 2014
  • Revision received July 24, 2014
  • Accepted August 2, 2014
  • Published first September 19, 2014.

Article Versions

  • Previous version (September 19, 2014 - 10:51).
  • Previous version (October 24, 2014 - 11:54).
  • You are viewing the most recent version of this article.
Copyright & Usage 
©2014 American Association for Cancer Research.

Author Information

  1. Alison Chan1,2,
  2. Ioannis Prassas1,2,
  3. Apostolos Dimitromanolakis2,
  4. Randall E. Brand3,
  5. Stefano Serra1,4,
  6. Eleftherios P. Diamandis1,2,5, and
  7. Ivan M. Blasutig1,5,*
  1. 1Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.
  2. 2Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada.
  3. 3University of Pittsburgh, Division of Gastroenterology, Hepatology & Nutrition, Pittsburgh, Pennsylvania.
  4. 4Department of Pathology, University Health Network, Toronto, Ontario, Canada.
  5. 5Department of Clinical Biochemistry, University Health Network, Toronto, Ontario, Canada.
  1. ↵*Corresponding Author:
    Ivan M. Blasutig, University Health Network, 200 Elizabeth Street, Room 3 EB 362, Toronto, ON, M5G 2C4, Canada. Phone: 416-340-4800, ext. 7199; Fax: 416-340-4215; E-mail: ivan.blasutig{at}uhn.ca
  1. A. Chan and I. Prassas contributed equally to this article.

View Full Text
PreviousNext
Back to top
Clinical Cancer Research: 20 (22)
November 2014
Volume 20, Issue 22
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Clinical Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Validation of Biomarkers That Complement CA19.9 in Detecting Early Pancreatic Cancer
(Your Name) has forwarded a page to you from Clinical Cancer Research
(Your Name) thought you would be interested in this article in Clinical Cancer Research.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Validation of Biomarkers That Complement CA19.9 in Detecting Early Pancreatic Cancer
Alison Chan, Ioannis Prassas, Apostolos Dimitromanolakis, Randall E. Brand, Stefano Serra, Eleftherios P. Diamandis and Ivan M. Blasutig
Clin Cancer Res November 15 2014 (20) (22) 5787-5795; DOI: 10.1158/1078-0432.CCR-14-0289

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Validation of Biomarkers That Complement CA19.9 in Detecting Early Pancreatic Cancer
Alison Chan, Ioannis Prassas, Apostolos Dimitromanolakis, Randall E. Brand, Stefano Serra, Eleftherios P. Diamandis and Ivan M. Blasutig
Clin Cancer Res November 15 2014 (20) (22) 5787-5795; DOI: 10.1158/1078-0432.CCR-14-0289
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Disclosure of Potential Conflicts of Interest
    • Disclaimer
    • Authors' Contributions
    • Grant Support
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • Telatinib for Pseudomyogenic Hemangioendothelioma
  • FA Pathway Controls Invasion via Ganglioside Accumulation
  • Combination Approach for Liquid Biopsies
Show more Biology of Human Tumors
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • CCR Focus Archive
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Clinical Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Clinical Cancer Research
eISSN: 1557-3265
ISSN: 1078-0432

Advertisement